{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,23]],"date-time":"2026-03-23T20:13:47Z","timestamp":1774296827461,"version":"3.50.1"},"reference-count":46,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T00:00:00Z","timestamp":1657152000000},"content-version":"am","delay-in-days":279,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular and Cellular Probes"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/j.mcp.2021.101749","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T02:11:06Z","timestamp":1625019066000},"page":"101749","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"special_numbering":"C","title":["Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms"],"prefix":"10.1016","volume":"59","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2509-2127","authenticated-orcid":false,"given":"Nastaran Sadat","family":"Savar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Vallet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masoumeh","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3117-3217","authenticated-orcid":false,"given":"Arash","family":"Arashkia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth","family":"Lundstrom","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Vignuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hamid Mahmoudzadeh","family":"Niknam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.mcp.2021.101749_bib1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0035671","article-title":"Leishmaniasis worldwide and global estimates of its incidence","volume":"7","author":"Alvar","year":"2012","journal-title":"PloS One"},{"key":"10.1016\/j.mcp.2021.101749_bib2","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/s13071-017-2028-5","article-title":"The history of leishmaniasis","volume":"10","author":"Steverding","year":"2017","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.mcp.2021.101749_bib3","first-page":"750","volume":"6","author":"Torres-Guerrero","year":"2017","journal-title":"Leishmaniasis: Rev."},{"key":"10.1016\/j.mcp.2021.101749_bib4","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.pt.2005.03.006","article-title":"Second-generation vaccines against leishmaniasis","volume":"21","author":"Coler","year":"2005","journal-title":"Trends Parasitol."},{"key":"10.1016\/j.mcp.2021.101749_bib5","doi-asserted-by":"crossref","first-page":"151","DOI":"10.3389\/fimmu.2016.00151","article-title":"Cutaneous leishmaniasis vaccination: a matter of quality","volume":"7","author":"De Luca","year":"2016","journal-title":"Front. Immunol."},{"key":"10.1016\/j.mcp.2021.101749_bib6","first-page":"1","article-title":"An overview on Leishmania vaccines: a narrative review article","volume":"6","author":"Rezvan","year":"2015","journal-title":"Vet. Res. Forum"},{"key":"10.1016\/j.mcp.2021.101749_bib7","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13071-016-1553-y","article-title":"Possibilities and challenges for developing a successful vaccine for leishmaniasis","volume":"9","author":"Srivastava","year":"2016","journal-title":"Parasites Vectors"},{"key":"10.1016\/j.mcp.2021.101749_bib8","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1590\/S0074-02762011000200011","article-title":"An experimental protocol for the establishment of dogs with long-term cellular immune reactions to Leishmania antigens","volume":"106","author":"eixeira Mc","year":"2011","journal-title":"Mem. Inst. Oswaldo Cruz"},{"key":"10.1016\/j.mcp.2021.101749_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0005527","article-title":"A third generation vaccine for human visceral leishmaniasis and post kala azar dermal leishmaniasis: first-in-human trial of Chad63-KH","volume":"11","author":"Osman","year":"2017","journal-title":"PLoS Neglected Trop. Dis."},{"key":"10.1016\/j.mcp.2021.101749_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijms19113605","article-title":"DNA vaccines-how far from clinical use?","volume":"19","author":"Hobernik","year":"2018","journal-title":"Int. J. Mol. Sci."},{"issue":"Suppl","key":"10.1016\/j.mcp.2021.101749_bib11","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1017\/S0031182006001831","article-title":"Leishmania vaccines: progress and problems","volume":"133","author":"Kedzierski","year":"2006","journal-title":"Parasitology"},{"key":"10.1016\/j.mcp.2021.101749_bib12","article-title":"An update on self-amplifying mRNA vaccine development","volume":"9","author":"Blakney","year":"2021","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcp.2021.101749_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/genes10030189","article-title":"RNA viruses as tools in gene therapy and vaccine development","volume":"10","author":"Lundstrom","year":"2019","journal-title":"Genes"},{"key":"10.1016\/j.mcp.2021.101749_bib14","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/nrd.2017.243","article-title":"mRNA vaccines - a new era in vaccinology","volume":"17","author":"Pardi","year":"2018","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.mcp.2021.101749_bib15","first-page":"109","article-title":"Alphavirus vectors for gene therapy applications BT - gene therapy for cancer","author":"Lundstrom","year":"2007"},{"key":"10.1016\/j.mcp.2021.101749_bib16","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1038\/sj.gt.3301004","article-title":"Induction of P815 tumor immunity by recombinant Semliki Forest virus expressing the P1A gene","volume":"6","author":"Colmenero","year":"1999","journal-title":"Gene Ther."},{"key":"10.1016\/j.mcp.2021.101749_bib17","first-page":"147","article-title":"Immunogene therapy of recurrent glioblastoma multiforme with a liposomally encapsulated replication-incompetent Semliki forest virus vector carrying the human interleukin-12 gene \u2014 a phase I\/II clinical protocol","volume":"64","author":"Ren","year":"2003","journal-title":"J. Neuro Oncol."},{"key":"10.1016\/j.mcp.2021.101749_bib18","first-page":"19","article-title":"Breakthrough in cancer therapy: encapsulation of drugs and viruses","volume":"11","author":"Lundstrom","year":"2002","journal-title":"Curr. Drug Discov."},{"key":"10.1016\/j.mcp.2021.101749_bib19","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1080\/17425247.2019.1653851","article-title":"Self-amplifying RNA virus vectors: clinical applications in cancer drug delivery","volume":"16","author":"Lundstrom","year":"2019","journal-title":"Expet Opin. Drug Deliv."},{"key":"10.1016\/j.mcp.2021.101749_bib20","article-title":"A comparison of plasmid DNA and mRNA as vaccine technologies","volume":"7","author":"Liu","year":"2019","journal-title":"Vaccines (Basel)"},{"key":"10.1016\/j.mcp.2021.101749_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/rmv.360","article-title":"Alphavirus vectors and vaccination","volume":"12","author":"Rayner","year":"2002","journal-title":"Rev. Med. Virol."},{"issue":"Pt 9","key":"10.1016\/j.mcp.2021.101749_bib22","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1099\/0022-1317-80-9-2287","article-title":"The molecular pathogenesis of Semliki Forest virus: a model virus made useful?","volume":"80","author":"Atkins","year":"1999","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mcp.2021.101749_bib23","doi-asserted-by":"crossref","first-page":"3873","DOI":"10.1128\/JVI.75.8.3873-3884.2001","article-title":"Biogenesis of the Semliki Forest virus RNA replication complex","volume":"75","author":"Kujala","year":"2001","journal-title":"J. Virol."},{"key":"10.1016\/j.mcp.2021.101749_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1093\/infdis\/jiu522","article-title":"Potent immune responses in rhesus macaques induced by nonviral delivery of a self-amplifying RNA vaccine expressing HIV type 1 envelope with a cationic nanoemulsion","volume":"211","author":"Bogers","year":"2015","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.mcp.2021.101749_bib25","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.1038\/emi.2013.54","article-title":"Rapidly produced SAM((R)) vaccine against H7N9 influenza is immunogenic in mice","volume":"2","author":"Hekele","year":"2013","journal-title":"Emerg. Microb. Infect."},{"key":"10.1016\/j.mcp.2021.101749_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161193","article-title":"Self-amplifying mRNA vaccines expressing multiple conserved influenza antigens confer protection against homologous and heterosubtypic viral challenge","volume":"11","author":"Magini","year":"2016","journal-title":"PloS One"},{"key":"10.1016\/j.mcp.2021.101749_bib27","unstructured":"N.S. Savar, D. Shengjuler, F. Doroudian, T. Vallet, A. Mac Kain, A. Arashkia, A. Khamesipour, K. Lundstrom, M. Vignuzzi, H. Mahmoudzadeh Niknam, An Alphavirus-Derived Self-Amplifying mRNA Expressing PpSP15-LmSTI1 Fusion Protein as a Vaccine Candidate against Cutaneous Leishmaniasis, Manuscr. Submitt. Publ. ((n.d.))."},{"key":"10.1016\/j.mcp.2021.101749_bib28","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/S1525-0016(02)00056-4","article-title":"Novel Semliki Forest virus vectors with reduced cytotoxicity and temperature sensitivity for long-term enhancement of transgene expression","volume":"7","author":"Lundstrom","year":"2003","journal-title":"Mol. Ther."},{"key":"10.1016\/j.mcp.2021.101749_bib29","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1093\/nar\/29.9.e45","article-title":"A new mathematical model for relative quantification in real-time RT-PCR","volume":"29","author":"Pfaffl","year":"2001","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcp.2021.101749_bib30","doi-asserted-by":"crossref","first-page":"e36","DOI":"10.1093\/nar\/30.9.e36","article-title":"Relative expression software tool (REST) for group-wise comparison and statistical analysis of relative expression results in real-time PCR","volume":"30","author":"Pfaffl","year":"2002","journal-title":"Nucleic Acids Res."},{"key":"10.1016\/j.mcp.2021.101749_bib31","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1006\/meth.2001.1262","article-title":"Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method","volume":"25","author":"Livak","year":"2001","journal-title":"Methods"},{"key":"10.1016\/j.mcp.2021.101749_bib32","doi-asserted-by":"crossref","first-page":"2469","DOI":"10.1056\/NEJMcibr2009737","article-title":"Amplifying RNA vaccine development","volume":"382","author":"Fuller","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.mcp.2021.101749_bib33","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21145130","article-title":"Self-amplifying RNA viruses as RNA vaccines","volume":"21","author":"Lundstrom","year":"2020","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.mcp.2021.101749_bib34","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1126\/science.1690918","article-title":"Direct gene transfer into mouse muscle in vivo","volume":"247","author":"Wolff","year":"1990","journal-title":"Science (80-. )"},{"key":"10.1016\/j.mcp.2021.101749_bib35","volume":"7","author":"Lundstrom","year":"2019"},{"key":"10.1016\/j.mcp.2021.101749_bib36","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1128\/mr.58.3.491-562.1994","article-title":"The alphaviruses: gene expression, replication, and evolution","volume":"58","author":"Strauss","year":"1994","journal-title":"Microbiol. Rev."},{"key":"10.1016\/j.mcp.2021.101749_bib37","doi-asserted-by":"crossref","first-page":"26446","DOI":"10.1038\/srep26446","article-title":"Impact of different promoters on episomal vectors harbouring characteristic motifs of matrix attachment regions","volume":"6","author":"Wang","year":"2016","journal-title":"Sci. Rep."},{"key":"10.1016\/j.mcp.2021.101749_bib38","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1006\/viro.1997.8878","article-title":"Replicon-helper systems from attenuated Venezuelan equine encephalitis virus: expression of heterologous genes in vitro and immunization against heterologous pathogens in vivo","volume":"239","author":"Pushko","year":"1997","journal-title":"Virology"},{"key":"10.1016\/j.mcp.2021.101749_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0117042","article-title":"Alphavirus replicon DNA expressing HIV antigens is an excellent prime for boosting with recombinant modified vaccinia Ankara (MVA) or with HIV gp140 protein antigen","volume":"10","author":"Knudsen","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.mcp.2021.101749_bib40","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S0147-9571(99)00014-4","article-title":"Semiliki forest virus vector carrying the bovine viral diarrhea virus NS3 (p80) cDNA induced immune responses in mice and expressed BVDV protein in mammalian cells","volume":"22","author":"Reddy","year":"1999","journal-title":"Comp. Immunol. Microbiol. Infect. Dis."},{"key":"10.1016\/j.mcp.2021.101749_bib41","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1099\/0022-1317-49-2-297","article-title":"Growth and release of several alphaviruses in chick and BHK cells","volume":"49","author":"Strauss","year":"1980","journal-title":"J. Gen. Virol."},{"key":"10.1016\/j.mcp.2021.101749_bib42","first-page":"55","article-title":"Certain aspects of foot--and--mouth disease. Virus production in growing BHK suspended cell cultures","volume":"35","author":"Barteling","year":"1976","journal-title":"Dev. Biol. Stand."},{"key":"10.1016\/j.mcp.2021.101749_bib43","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1023\/A:1007951813755","article-title":"Adaptation of BHK cells producing a recombinant protein to serum-free media and protein-free medium","volume":"26","author":"Cruz","year":"1998","journal-title":"Cytotechnology"},{"key":"10.1016\/j.mcp.2021.101749_bib44","doi-asserted-by":"crossref","first-page":"470","DOI":"10.4049\/jimmunol.0900265","article-title":"Immunization with the DNA-encoding N-terminal domain of proteophosphoglycan of Leishmania donovani generates Th1-type immunoprotective response against experimental visceral leishmaniasis","volume":"183","author":"Samant","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.mcp.2021.101749_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002417","article-title":"Progressive visceral leishmaniasis is driven by dominant parasite-induced STAT6 activation and STAT6-dependent host arginase 1 expression","volume":"8","author":"Osorio","year":"2012","journal-title":"PLoS Pathog."},{"key":"10.1016\/j.mcp.2021.101749_bib46","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3389\/fcimb.2012.00083","article-title":"The early interaction of Leishmania with macrophages and dendritic cells and its influence on the host immune response","volume":"2","author":"Liu","year":"2012","journal-title":"Front. Cell. Infect. Microbiol."}],"container-title":["Molecular and Cellular Probes"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850821000566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0890850821000566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T14:16:51Z","timestamp":1760192211000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0890850821000566"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10]]},"references-count":46,"alternative-id":["S0890850821000566"],"URL":"https:\/\/doi.org\/10.1016\/j.mcp.2021.101749","relation":{},"ISSN":["0890-8508"],"issn-type":[{"value":"0890-8508","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Quantitative evaluation of PpSP15-LmSTI1 fusion gene expression following transfection with an alphavirus-derived self-amplifying mRNA and conventional DNA vaccine platforms","name":"articletitle","label":"Article Title"},{"value":"Molecular and Cellular Probes","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.mcp.2021.101749","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"101749"}}